Synthetic process for preparing 2-((2-ethoxy-2-oxoethyl)(methyl)amino)-2-oxoethyl 5-tetradecyloxy)furan-2-carboxylate

Inventors

SHAW, Anthony Adrian • Khumtaveeporn, Kanjai • Krasik, Pavel

Assignees

Dermira Inc

Interested in licensing this patent?

MTEC can help explore whether this patent might be available for licensing for your application.

Publication Number

US-9745277-B2

Patent

Publication Date

2017-08-29

Expiration Date


Abstract

Disclosed herein are processes for forming 2-((2-ethoxy-2-oxoethyl)(methyl)amino)-2-oxoethyl 5-tetradecyloxy)furan-2-carboxylate:

Core Innovation

The invention relates to a process for preparing a compound of Formula (I), including a TOFA prodrug described as 2-((2-ethoxy-2-oxoethyl)(methyl)amino)-2-oxoethyl 5-tetradecyloxy)furan-2-carboxylate. The process includes providing a mixture of a compound of Formula (II) in an ether solvent and combining a compound of Formula (III) with the mixture and a base. The substituent variables are defined with R1 as C10-20 alkyl, R2 as C1-4 alkyl, and X as a leaving group.

A key aspect is carrying out the preparation in an ether solvent, with variants specifying a solvent having a boiling point below 100°C. In the described route, the mixture of Formula (II) in the ether is combined with Formula (III) under base to form the coupling product, using X as a leaving group. The document emphasizes that the ether solvent can be used across steps to improve process throughput.

In the illustrated example, the route uses an MTBE-mediated two-step sequence in which the same ether (MTBE) is used across steps, including preparation involving chloroacetyl chloride and subsequent coupling using a base. The document states improved scalability and yield, including scalability to about 13 kg and yields of about 60–80% for the first step and about 83% for the coupling product, with increased throughput attributed to reuse of MTBE across steps.

Claims Coverage

Two independent claims define the claimed process for preparing a compound of Formula (I), with a shared set of inventive features: preparation using a Formula (II) mixture in an ether/low-boiling solvent and coupling with a Formula (III) compound in the presence of a base, where R1 is C10-20 alkyl, R2 is C1-4 alkyl, and X is a leaving group/halogen.

Providing Formula (II) Mixture in Ether Solvent

Providing a mixture of a compound of Formula (II) in an ether solvent.

Coupling Formula (III) with Mixture and Base

Combining a compound of Formula (III) with the mixture and a base.

R1 and R2 Substituent Ranges

R1 is C10-20 alkyl and R2 is C1-4 alkyl.

Leaving Group X

X is a leaving group.

Providing Formula (II) Mixture in Below-100°C Boiling Solvent

Providing a mixture of a compound of Formula (II) in a solvent having a boiling point of below 100°C.

Organic Base Coupling with Halogen Leaving Group

Combining a compound of Formula (III) with the mixture and an organic base, wherein X is halogen.

Across both independent claims, the inventive process centers on preparing a mixture of Formula (II) in an ether (or below-100°C boiling solvent) and combining Formula (III) with the mixture and a base to form a compound of Formula (I), while defining R1 as C10-20 alkyl, R2 as C1-4 alkyl, and X as the leaving group/halogen.

Stated Advantages

Improved scalability.

Improved yield (as stated for the example).

Improved throughput due to reuse of MTBE across steps.

Documented Applications

Not explicitly described in patent.

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.